Non-steroidal mineralocorticoid receptor antagonist

This page covers all Non-steroidal mineralocorticoid receptor antagonist drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Mineralocorticoid receptor (MR).

Targets

Mineralocorticoid receptor (MR)

Marketed (1)

• Finerenone (BAY 94-8862) · University Medical Center Groningen · Cardiovascular, Nephrology
  Finerenone is a non-steroidal mineralocorticoid receptor antagonist that blocks aldosterone signaling to reduce inflammation and fibrosis in the kidneys and cardiovascular system.

Phase 3 pipeline (1)

• Finerenone (BAY94-8862) · Bayer · Cardiovascular, Nephrology
  Finerenone is a non-steroidal mineralocorticoid receptor antagonist that blocks aldosterone signaling to reduce inflammation and fibrosis in the kidneys and cardiovascular system.